Literature DB >> 33986581

A Common Drug Causing a Common Side Effect at an Uncommon Time: Metformin-Induced Chronic Diarrhea and Weight Loss After Years of Treatment.

Karthik Subramaniam1, Manoj P Joseph2, Lakshmi A Babu2.   

Abstract

Entities:  

Year:  2021        PMID: 33986581      PMCID: PMC8061542          DOI: 10.2337/cd20-0101

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


× No keyword cloud information.
  7 in total

1.  Metformin as a cause of late-onset chronic diarrhea.

Authors:  M T Foss; K D Clement
Journal:  Pharmacotherapy       Date:  2001-11       Impact factor: 4.705

Review 2.  Understanding and overcoming metformin gastrointestinal intolerance.

Authors:  Fabrice Bonnet; André Scheen
Journal:  Diabetes Obes Metab       Date:  2017-02-22       Impact factor: 6.577

3.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

Review 4.  Diabetes Mellitus and the Colon.

Authors:  Marc S Piper; Richard J Saad
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

5.  Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes.

Authors:  Sonia García-Calzón; Alexander Perfilyev; Mats Martinell; Monta Ustinova; Sebastian Kalamajski; Paul W Franks; Karl Bacos; Ilze Elbere; Jussi Pihlajamäki; Petr Volkov; Allan Vaag; Leif Groop; Marlena Maziarz; Janis Klovins; Emma Ahlqvist; Charlotte Ling
Journal:  Sci Transl Med       Date:  2020-09-16       Impact factor: 17.956

Review 6.  Effects of metformin on weight loss: potential mechanisms.

Authors:  Steven K Malin; Sangeeta R Kashyap
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

7.  Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.

Authors: 
Journal:  Diabetes Care       Date:  2012-04       Impact factor: 19.112

  7 in total
  1 in total

1.  α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation.

Authors:  Nosipho Cele; Paul Awolade; Pule Seboletswe; Kolawole Olofinsan; Md Shahidul Islam; Parvesh Singh
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.